A role for the vacuolating cytotoxin, VacA, in colonization and helicobacter pylori-induced metaplasia in the stomach

Journal of Infectious Diseases

Volumn 210, Issue 6, 2014, Pages 954-963

  Winter, Jody A ^a   Letley, Darren P ^a   Cook, Katherine W ^a   Rhead, Joanne L ^a   Zaitoun, Abed A M ^b   Ingram, Richard J M ^a   Amilon, Karin R ^a   Croxall, Nicola J ^a   Kaye, Phillip V ^b   Robinson, Karen ^a   Atherton, John C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Colonization; Gastric cancer; Helicobacter pylori; Pathogenesis; SPEM; Virulence

Indexed keywords

CAGA PROTEIN; VACUOLATING TOXIN;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CAGA GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTRITIS; GENE; GENETIC POLYMORPHISM; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MALE; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH MUCOSA; TOXIN SYNTHESIS; VACA GENE;

COLONIZATION; GASTRIC CANCER; HELICOBACTER PYLORI; PATHOGENESIS; SPEM; VIRULENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MICE; MICE, INBRED C57BL; MIDDLE AGED; STOMACH; VACUOLES; YOUNG ADULT;

EID: 84907303505     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu154     Document Type: Article

References (37)

1. Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995; 9(Suppl 2):59-69.
2. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Ann Rev Microbiol 2000; 54:615-40.
3. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402.
4. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997; 24:2-17.
5. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19:449-90.
6. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992; 267:10570-5.
7. Cover TL, Krishna US, Israel DA, Peek RM Jr. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res 2003; 63:951-7.
8. Gebert B, FischerW, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003; 301:1099-102.
9. Noto JM, Peek RM Jr. The Helicobacter pylori cag pathogenicity island. Methods Mol Biol 2012; 921:41-50.
10. Letley DP, Rhead JL, Twells RJ, Dove B, Atherton JC. Determinants of non-toxicity in the gastric pathogen Helicobacter pylori. J Biol Chem 2003; 278:26734-41.
11. Rhead JL, Letley DP, Mohammadi M, et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007; 133:926-36.
12. McClain MS, Cao P, Iwamoto H, et al. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J Bacteriol 2001; 183:6499-508.
13. Ji X, Fernandez T, Burroni D, et al. Cell specificity of Helicobacter pylori cytotoxin is determined by a short region in the polymorphic midregion. Infect Immun 2000; 68:3754-7.
14. Atherton JC. The pathogenesis of Helicobacter pylori-induced gastroduodenal diseases. Ann Rev Pathol 2006; 1:63-96.
15. Yordanov D, Boyanova L, Markovska R, Gergova G, Mitov I. Significance of Helicobacter pylori vacA intermediate region genotyping-a Bulgarian study. Diagn Microbiol Infect Dis 2012; 74:253-7.
16. Ferreira RM, Figueiredo C, Bonet C, et al. Helicobacter pylori vacA intermediate region genotyping and progression of gastric preneoplastic lesions. Am J Gastroenterol 2012; 107:145-6.
17. Basso D, Zambon CF, Letley DP, et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008; 135:91-9.
18. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997; 112:1386-97.
19. Barrozo RM, Cooke CL, Hansen LM, et al. Functional plasticity in the type IV secretion system of Helicobacter pylori. PLoS Pathog 2013; 9: e1003189.
20. Philpott DJ, Belaid D, Troubadour P, et al. Reduced activation of inflammatory responses in host cells by mouse-adapted Helicobacter pylori isolates. Cell Microbiol 2002; 4:285-96.
21. Arnold IC, Lee JY, Amieva MR, et al. Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology 2011; 140:199-209.
22. Algood HM, Torres VJ, Unutmaz D, Cover TL. Resistance of primary murine CD4+ T cells to Helicobacter pylori vacuolating cytotoxin. Infect Immun 2007; 75:334-41.
23. Eaton KA, Cover TL, Tummuru MK, Blaser MJ, Krakowka S. Role of vacuolating cytotoxin in gastritis due to Helicobacter pylori in gnotobiotic piglets. Infect Immun 1997; 65:3462-4.
24. Wirth HP, Beins MH, Yang M, Tham KT, Blaser MJ. Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains. Infect Immun 1998; 66:4856-66.
25. Salama NR, Otto G, Tompkins L, Falkow S. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect Immun 2001; 69:730-6.
26. Oertli M, Noben M, Engler DB, et al. Helicobacter pylori gammaglutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance. PNAS (USA) 2013; 110:3047-52.
27. Cover TL, Tummuru MK, Cao P, Thompson SA, Blaser MJ. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994; 269:10566-73.
28. Miles AA, Misra SS, Irwin JO. The estimation of the bactericidal power of the blood. J Hyg 1938; 38:732-49.
29. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney System. InternationalWorkshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
30. Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270:17771-7.
31. Atherton JC, Cover TL, Twells RJ, Morales MR, Hawkey CJ, Blaser MJ. Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J Clin Microbiol 1999; 37:2979-82.
32. Argent RH, Thomas RJ, Aviles-Jimenez F, et al. Toxigenic Helicobacter pylori infection precedes gastric hypochlorhydria in cancer relatives, and H. pylori virulence evolves in these families. Clin Cancer Res 2008; 14:2227-35.
33. van Doorn NE, Namavar F, Sparrius M, et al. Helicobacter pyloriassociated gastritis in mice is host and strain specific. Infect Immun 1999; 67:3040-6.
34. Crabtree JE, Ferrero RL, Kusters JG. The mouse colonizing Helicobacter pylori strain SS1 may lack a functional cag pathogenicity island. Helicobacter 2002; 7:139-40; author reply 40-1.
35. Kawazoe T, Sakagami T,Nakajima K, et al. Role of bacterial strain diversity of Helicobacter pylori in gastric carcinogenesis induced by N-methyl-Nnitrosourea in Mongolian gerbils. Helicobacter 2007; 12:213-23.
36. Syu LJ, El-Zaatari M, Eaton KA, et al. Transgenic expression of interferon-gamma in mouse stomach leads to inflammation, metaplasia, and dysplasia. Am J Pathol 2012; 181:2114-25.
37. Wiedemann T, Loell E, Mueller S, et al. Helicobacter pylori cagpathogenicity island-dependent early immunological response triggers later precancerous gastric changes in Mongolian gerbils. PloS One 2009; 4:e4754.